Bhusal, RP, Patel, K, Kwai, BXC, Swartjes, A, Bashiri, G, Reynisson, J, Sperry, J and Leung, IKH (2017) Development of NMR and thermal shift assays for the evaluation of Mycobacterium tuberculosis isocitrate lyase inhibitors. MedChemComm, 8 (11). 2155 - 2163. ISSN 2040-2511

[thumbnail of J Reynisson - Development of NMR and thermal shift....pdf]
J Reynisson - Development of NMR and thermal shift....pdf - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (1MB) | Preview


The enzymes isocitrate lyase (ICL) isoforms 1 and 2 are essential for Mycobacterium tuberculosis survival within macrophages during latent tuberculosis (TB). As such, ICLs are attractive therapeutic targets for the treatment of tuberculosis. However, there are few biophysical assays that are available for accurate kinetic and inhibition studies of ICL in vitro. Herein we report the development of a combined NMR spectroscopy and thermal shift assay to study ICL inhibitors for both screening and inhibition constant (IC50) measurement. Operating this new assay in tandem with virtual high-throughput screening has led to the discovery of several new ICL1 inhibitors.

Item Type: Article
Uncontrolled Keywords: tuberculosis
Subjects: Q Science > QD Chemistry
Divisions: Faculty of Natural Sciences > School of Chemical and Physical Sciences
Related URLs:
Depositing User: Symplectic
Date Deposited: 28 Feb 2019 10:40
Last Modified: 28 Feb 2019 10:40

Actions (login required)

View Item
View Item